Tirzepatide (Brand name Mounjaro)
Tirzepatide is similar to Semaglutide in that it’s also a glucagon-like peptide-1 (GLP-1) receptor agonist. This means it works by mimicking the effects of GLP-1, thereby enhancing insulin secretion, slowing down the absorption of glucose from the intestines, and reducing the amount of glucose produced by the liver. The medication also blocks ghrelin, your hunger hormone, so you feel fuller throughout the day. Tirzepatide helps to lower blood sugar levels in individuals with type 2 diabetes and helps those lose weight with a higher BMI. However, Tirzepatide also activates a second receptor called the glucose-dependent insulinotropic polypeptide (GIP). The GIP hormone can also trigger insulin creation and sensations of fullness. This means Tirzepatide offers a two-punch approach when it comes to an extra weight loss boost compared to Semaglutide.
Tirzepatide is self-administered by a weekly injection. Tirzepatide is often dosed differently than Semaglutide, where your dose is slowly titrated up over 18 weeks until we achieve maintenance dosing. With Tirzepatide people will often start with a low dose and may continue at that low dose or a slightly higher dose, but there is no escalation to maintenance like there is with Semaglutide.
The Semaglutide we provide is compounded with vitamin B3 to help minimize side effects. We obtain the medication from a Texas-based Pharmacy that is a PCAB®-accredited 503A compounding pharmacy. Submit a request to learn more!